CLINICAL TRIALS PROFILE FOR PHENPROCOUMON
✉ Email this page to a colleague
All Clinical Trials for phenprocoumon
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00528671 ↗ | Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications | Terminated | Klinikum Ludwigshafen | Phase 4 | 2006-01-01 | We aim to investiagte whether very low dose self management of oral anticoagulation is superior to low dose oral anticoagulation in order to prevent bleeding events in patients undergoing mechanuical heart valve replacement. |
NCT00528671 ↗ | Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications | Terminated | University of Kiel | Phase 4 | 2006-01-01 | We aim to investiagte whether very low dose self management of oral anticoagulation is superior to low dose oral anticoagulation in order to prevent bleeding events in patients undergoing mechanuical heart valve replacement. |
NCT00528671 ↗ | Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications | Terminated | Heart and Diabetes Center North-Rhine Westfalia | Phase 4 | 2006-01-01 | We aim to investiagte whether very low dose self management of oral anticoagulation is superior to low dose oral anticoagulation in order to prevent bleeding events in patients undergoing mechanuical heart valve replacement. |
NCT00586287 ↗ | Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon | Completed | Cantonal Hospital of St. Gallen | Phase 4 | 2007-01-01 | Oral anticoagulation is often initiated in hospitalized patients. Although the therapeutic range of phenprocoumon is narrow, the individual drug demands unfortunately vary greatly between persons. Our group recently developed two dosing algorithms for the initiation of anticoagulation based on clinical predictors such as age, gender, body weight and laboratory values. The aim of the proposed study is to prospectively evaluate the efficacy and safety of these two algorithms in medical and orthopedic inpatients, as well as in a group of outpatients and possibly in a geriatric collective. |
NCT00895505 ↗ | D-Dimer Guided Oral Anticoagulant Treatment (OAT) | Unknown status | German Federal Ministry of Education and Research | Phase 3 | 2008-02-01 | This clinical trial will investigate the hypothesis that D-Dimer testing can be successfully used to tailor the duration of OAT in patients after an unprovoked episode of deep venous thrombosis (DVT) using a prospective, randomized, and controlled design. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for phenprocoumon
Condition Name
Clinical Trial Locations for phenprocoumon
Trials by Country
Clinical Trial Progress for phenprocoumon
Clinical Trial Phase
Clinical Trial Sponsors for phenprocoumon
Sponsor Name